mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |